BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11848539)

  • 21. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas.
    Nabeshima K; Suzumiya J; Nagano M; Ohshima K; Toole BP; Tamura K; Iwasaki H; Kikuchi M
    J Pathol; 2004 Mar; 202(3):341-51. PubMed ID: 14991900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of chemokines, chemokine receptors, cytokines and cytokine receptors in diffuse large B cell malignant lymphoma.
    Fujii A; Ohshima K; Hamasaki M; Makimoto Y; Haraoka S; Utsunomiya H; Okazaki M; Kikuchi M
    Int J Oncol; 2004 Mar; 24(3):529-38. PubMed ID: 14767537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. M-FISH in gastric lymphoma.
    Ferti AD; Panani AD; Stamouli MI; Rondogianni DP; Raptis SA; Young BD
    Cancer Genet Cytogenet; 2004 Nov; 155(1):63-6. PubMed ID: 15527904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathology of intestinal lymphomas].
    Chott A
    Pathologe; 2003 Feb; 24(1):15-27. PubMed ID: 12601474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
    Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
    Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric lymphomas: genetics and resistance to H. pylori eradication.
    Isaacson PG; Du MQ
    Verh Dtsch Ges Pathol; 2003; 87():116-22. PubMed ID: 16888902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic and clinicopathological characterization by fluorescence in situ hybridization on paraffin-embedded tissue sections of twenty-six cases with malignant lymphoma of small intestine.
    Yoshida N; Nomura K; Wakabayashi N; Konishi H; Nishida K; Taki T; Mitsufuji S; Horiike S; Yanagisawa A; Yamagishi H; Nakamura S; Okanoue T; Taniwaki M
    Scand J Gastroenterol; 2006 Feb; 41(2):212-22. PubMed ID: 16484127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification.
    Chinen K; Izumo T
    Ann Hematol; 2005 Aug; 84(8):498-505. PubMed ID: 15782345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
    Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
    Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological study of primary gastric lymphoma.
    Al-Shehabi ZA; Zezafon HB; Saleh RS
    Saudi Med J; 2007 Oct; 28(10):1506-10. PubMed ID: 17914509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [World Health Organization (WHO) classification of malignant lymphoma--how is the WHO now?].
    Nakamura S
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):149-57. PubMed ID: 14997743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant lymphomas--the end of a long dispute?].
    Borisch B
    Rev Med Suisse Romande; 1999 Oct; 119(10):769-73. PubMed ID: 10582487
    [No Abstract]   [Full Text] [Related]  

  • 36. [The concept of REAL classification, a new classification of human malignant lymphomas].
    Mori S
    Rinsho Ketsueki; 1998 Apr; 39(4):242-3. PubMed ID: 9597885
    [No Abstract]   [Full Text] [Related]  

  • 37. New Insights into Lymphoma Pathogenesis.
    Elenitoba-Johnson KSJ; Lim MS
    Annu Rev Pathol; 2018 Jan; 13():193-217. PubMed ID: 29140757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [REAL--why again a new classification system for lymphomas?].
    Franssila K
    Duodecim; 1998; 114(12):1260-8. PubMed ID: 11524772
    [No Abstract]   [Full Text] [Related]  

  • 39. [Basis of malignant lymphoma. 2. Etiological mechanism (gene abnormalities)].
    Seto M
    Nihon Naika Gakkai Zasshi; 2008 Jul; 97(7):1524-30. PubMed ID: 18720592
    [No Abstract]   [Full Text] [Related]  

  • 40. Lymphoma.
    Curr Opin Oncol; 1995 Sep; 7(5):B79-89. PubMed ID: 8541378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.